AIDX
20/20 Biolabs, Inc. Common Stock
NASDAQ: AIDX · HEALTHCARE · MEDICAL DEVICES
$1.49
-1.97% today
Updated 2026-05-05
Market cap
$15.62M
P/E ratio
—
P/S ratio
7.64x
EPS (TTM)
$-0.36
Dividend yield
—
52W range
$1 – $50
Volume
0.2M
20/20 Biolabs, Inc. Common Stock (AIDX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $427000.00 | $313207.00 | $277047.00 | $288300.00 | $2.33M | $9.62M | $11.06M | $1.42M | $1.75M | $2.05B |
| Revenue growth (YoY) | — | -26.6% | -11.5% | +4.1% | +708.4% | +312.9% | +14.9% | -87.1% | +23.0% | +116608.5% |
| Cost of revenue | $256220.00 | $182275.00 | $217595.00 | $263917.00 | $1.45M | $4.93M | $5.94M | $1.32M | $1.39M | $1.44B |
| Gross profit | $170780.00 | $130932.00 | $59452.00 | $24383.00 | $877174.00 | $4.69M | $5.12M | $109138.00 | $360311.00 | $604.54M |
| Gross margin | 40.0% | 41.8% | 21.5% | 8.5% | 37.6% | 48.8% | 46.3% | 7.7% | 20.6% | 29.6% |
| R&D | $424426.00 | $267063.00 | $234492.00 | $195041.00 | $338874.00 | $193368.00 | $120043.00 | $1.41M | $1.26M | $592.57M |
| SG&A | — | — | — | — | — | — | — | $5.06M | $4.76M | $3.34M |
| Operating income | $-2.23M | $-1.28M | $-1.47M | $-2.47M | $-2.03M | $1.94M | $1.68M | $-6.36M | $-5.66M | $-3.33B |
| Operating margin | -522.4% | -408.4% | -532.1% | -855.8% | -87.1% | 20.2% | 15.2% | -446.6% | -323.1% | -162.9% |
| EBITDA | $-2.21M | $-1.27M | $-1.44M | $-2.42M | $-1.97M | $2.07M | $1.97M | $-6.19M | $-5.53M | $-3.33B |
| EBITDA margin | -516.5% | -405.0% | -521.0% | -840.6% | -84.3% | 21.5% | 17.8% | -434.9% | -315.3% | -162.9% |
| EBIT | $-2.23M | $-1.28M | $-1.47M | $-2.47M | $-2.03M | $1.94M | $1.68M | $-6.36M | $-5.66M | — |
| Interest expense | $9472.00 | — | — | — | — | $12930.00 | $15685.00 | $27915.00 | $12646.00 | $-156.21M |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.23M | $-1.26M | $-1.46M | $-2.43M | $-2.02M | $2.07M | $2.19M | $-6.39M | $-5.55M | $-3.74B |
| Net income growth (YoY) | — | +43.3% | -15.7% | -65.8% | +16.6% | +202.5% | +5.6% | -392.3% | +13.1% | -67245.9% |
| Profit margin | -521.8% | -403.6% | -528.1% | -841.3% | -86.8% | 21.5% | 19.8% | -448.7% | -316.8% | -182.8% |